Fonteh, Cheryl N.
Mathias, Marc T.
Mandava, Naresh
Manoharan, Niranjan
Lynch, Anne M.
Navo, Roxanne
Patnaik, Jennifer L.
,
Akau, Melanie
Christopher, Karen L.
Davidson, Richard
Eshete, Ruth T.
Graef, C. Rob
Hauswirth, Scott
Lynch, Anne M.
Oliver, Scott N.
Olson, Jeffery L.
Palestine, Alan G.
Smith, Jesse M.
Wagner, Brandie D.
Article History
Received: 31 May 2022
Accepted: 7 September 2022
First Online: 2 October 2022
Declarations
:
: Patients with a diagnosis of AMD were recruited into a Colorado AMD registry (COMIRB number 14–0740) and informed consent for inclusion was obtained. All methods were carried out in accordance with relevant guidelines and in accordance with the Declaration of Helsinki. The following institutions/ licensing committees approved this experiment: Food and Drug Administration (FDA), the Office of Human Research Protections (OHRP), the People at the Colorado Multiple Institutional Review Board (COMIRB), the patient’s doctor and rest of the study team, and the Department of Ophthalmology at the University of Colorado.
: Not applicable.
: The authors declare they have no competing interests.